Back to mobile site

Analyst Says Buy the Dip in Health Management (HMA) Shares; General Counsel Resignation Not Related to Litigation

January 10, 2012 1:19 PM EST
Get Alerts HMA Hot Sheet
Price: $10.54 --0%

Rating Summary:
    4 Buy, 15 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Susquehanna analyst A.J. Rice believes the recent selloff in shares of Health Management Associates (NYSE: HMA) presents a strategic buying opportunity for investors. The stock fell more than 7 percent on Monday and is down another 22-plus percent Tuesday afternoon following news the company's general counsel resigned.

Rice states the resignation of the general counsel is not directly correlated to the two pending federal subpoenas or former employee lawsuit. According to Health Management Associates, the resignation of Timothy Parry was a personal decision and not related to the litigation. The company also confirmed compliance activities are not reported to the general counsel, but actually go directly to an independent committee of directors.

Rice highlights the company continues to post solid growth despite government reimbursement challenges.

Susquehanna currently has a Positive rating and $11 price target on shares of Health Management Associates.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Litigation

Related Entities

Susquehanna International Group of Companies